Simon Kelly

Has open position

Professor

University of Newcastle
Country flagAustralia

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Positions (1)

Publisher
source

University of Newcastle

University of Newcastle

This PhD project at the University of Newcastle investigates why people with irritable bowel syndrome (IBS) respond differently to synbiotic dietary supplements. The research combines microbiome science, gut barrier biology, immunology, nutrition and clinical research within an academic–industry collaboration with Epetōme. The programme begins with an in vitro phenotyping phase using archived blood and gut biopsy samples from people with IBS. Patient-derived immune and epithelial models will be used to reproduce IBS-related inflammatory and barrier dysfunction responses. Approximately 20 samples representing different IBS subtypes will be screened to identify biologically responsive categories and establish criteria for the subsequent human trial. The synbiotic formulation contains Lactobacilli and Bifidobacteria strains together with fructo-oligosaccharides and micronutrients supporting gut barrier function. The project will examine how the formulation modulates immune activation and epithelial integrity. It will then progress to a 12-week randomised, double-blind, placebo-controlled clinical trial in biologically defined IBS participants. Research activities will include assessment of IBS symptom severity, digestive wellbeing, gut barrier-associated biomarkers such as LBP and zonulin, low-grade inflammatory signalling, energy and fatigue outcomes, and food sensitivity or reactivity. Targeted metabolite profiling of stool and plasma will investigate short-chain fatty acids, tryptophan-pathway intermediates and other host–microbiome signatures associated with symptom improvement. The project will also explore whether effects persist after supplementation through a detraining or washout period, and whether biomarker changes correlate with clinical responses. Integrated analyses across ex vivo models, biomarkers and clinical data are expected to support multiple publications, precision nutrition approaches and evidence-based product development. Supervised by Professor Simon Kelly and delivered with Epetōme, the project offers experience spanning laboratory models, biomarker analysis, clinical trial research and translational gut-health innovation.

Posted Yesterday